Overall, low expression of CDH11, COL6A3, EDNRA, and SERPINF1 mRNA is significantly associated with mild clinical-pathological parameters in BC patients and is significantly lowered in the early disease stages. This evidence concerns the gene SERPINF1 and breast cancer.